000902:SSEYONFER Agricultural Technology Co., Ltd. Analysis
Data as of 2026-07-21 - not real-time
CN¥13.55
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
YONFER Agricultural Technology is trading well below its discounted cash‑flow derived fair value, offering roughly a quarter upside based on intrinsic calculations. The stock trades at a modest PE near the low‑teens and a P/B around 1.4, while delivering a 1.5% dividend with a comfortable payout ratio, suggesting earnings quality and dividend sustainability. Technical signals are mixed: the 20‑day moving average sits below the 50‑day and 200‑day averages, indicating a bearish trend, yet the MACD has turned bullish and the RSI is in the low 60s, hinting at short‑term momentum. Volatility remains high at around 40% and the beta is slightly negative, which can amplify price swings. Fundamentally, the company posts solid top‑line growth of nearly 18% YoY, healthy operating margins and a low debt‑to‑equity profile, with cash on hand exceeding total debt.
Given the sizable upside potential, strong cash generation, and limited leverage, the stock appears undervalued despite near‑term price pressure. However, the high volatility and recent bearish trend advise caution, making a measured approach prudent.
Given the sizable upside potential, strong cash generation, and limited leverage, the stock appears undervalued despite near‑term price pressure. However, the high volatility and recent bearish trend advise caution, making a measured approach prudent.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram despite overall bearish trend
- RSI approaching overbought levels
- Strong support around the low‑12s
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF‑derived upside of roughly 25‑30%
- Robust revenue growth and low leverage
- Sustainable dividend yield with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term demand for fertilizers in China
- Consistent profitability and cash generation
- Attractive valuation relative to peers and growth prospects
Key Metrics & Analysis
Financial Health
Revenue Growth17.80%
Profit Margin8.46%
P/E Ratio10.8
ROE13.31%
ROA6.38%
Debt/Equity15.69
P/B Ratio1.4
Op. Cash FlowCN¥1.7B
Free Cash FlowCN¥-78366240
Technical Analysis
TrendBearish
RSI62.8
SupportCN¥11.32
ResistanceCN¥13.80
MA 20CN¥12.40
MA 50CN¥12.93
MA 200CN¥15.12
MACDBullish
VolumeStable
Fear & Greed Index89.91
Valuation
Fair ValueCN¥26.84
Target PriceCN¥17.23
Upside/Downside27.18%
GradeUndervalued
TypeBlend
Dividend Yield1.48%
Risk Assessment
Beta-0.23
Volatility40.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.